Kimia Biosciences Limited at its board meeting held on May 30, 2022 appointed Mr. Sameer Goel as Chief Executive Officer of the Company. Mr. Sameer Goel holds a tall stature in the Indian API market with more than 23 years of experience and has strong multi-dimensional capabilities in the areas of Business Development, Product Development, Strategic Marketing and Operations Management.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.07 INR | -2.64% |
|
-3.31% | +41.49% |
1st Jan change | Capi. | |
---|---|---|
+41.49% | 30.32M | |
+55.19% | 801B | |
+47.26% | 631B | |
-6.09% | 359B | |
+21.92% | 337B | |
+18.40% | 245B | |
+3.64% | 231B | |
+12.98% | 219B | |
+10.86% | 171B | |
-2.78% | 161B |
- Stock Market
- Equities
- KIMIABL Stock
- News Kimia Biosciences Limited
- Kimia Biosciences Limited Appoints Sameer Goel as Chief Executive Officer